Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 404-370-8 | CAS number: 126990-35-0 DCPMS; DYNASYLAN 9415; EURENOR 5023; SAN-30; WACKER SILAN CP2-DIMETHOXY; Z-6228
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
In the key study performed according to OECD Test Guideline 406 (guinea pig maximisation test) and in compliance with GLP, dicyclopentyl(dimethoxy)silane (CAS 126990-35-0) was not sensitising to the skin (Safepharm Laboratories Ltd., 1996a).
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 03.07.1995 to 10.08.1995
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- other: 92/69/EEC
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- GLP compliance:
- yes
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- An LLNA study was not performed because there is an existing reliable study for skin sensitisation using the Guinea Pig Maximisation test method. Furthermore, the LLNA test method is not considered to be suitable for substances that contain silicon. Please refer to the attached document for further details.
- Species:
- guinea pig
- Strain:
- Dunkin-Hartley
- Sex:
- male
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: David Hall Ltd., UK
- Age at study initiation: 8-12 weeks
- Weight at study initiation: 324-396 g
- Housing: Individual or paired in polypropylene cages
- Diet (e.g. ad libitum):
- Water (e.g. ad libitum):
- Acclimation period: At least five days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 18-21
- Humidity (%): 46-70
- Air changes (per hr): 15
- Photoperiod (hrs dark / hrs light): 12/12
IN-LIFE DATES: From: 03.07.1995 to 10.08.1995 - Route:
- intradermal and epicutaneous
- Vehicle:
- arachis oil
- Concentration / amount:
- Concentration of test material and vehicle used at induction: 25% w/v in arachis oil BP for intradermal induction. 100% for topical induction Concentration of test material and vehicle used for each challenge: 100% and 25% v/v in arachis oil BP.
- Route:
- epicutaneous, occlusive
- Vehicle:
- arachis oil
- Concentration / amount:
- Concentration of test material and vehicle used at induction: 25% w/v in arachis oil BP for intradermal induction. 100% for topical induction Concentration of test material and vehicle used for each challenge: 100% and 25% v/v in arachis oil BP.
- No. of animals per dose:
- Test group: 20
Negative control group: 10 - Details on study design:
- RANGE FINDING TESTS: Intradermal induction: 0.1 ml of 1, 5, 10 and 25% w/v in arachis oil B.P. were tested in four guinea pigs by injection. Erythema was scored up to seven days after the injection. The highest concentration to cause only mild to moderate skin irritation, and which was well tolerated systemically was selected for the intradermal induction stage of the main study.
Topical induction: Two guinea pigs (intradermally injected with FCA 14 days earlier) were treated with undiluted test substance and 75, 50 ad 25% v/v in arachis oil B.P. Applications were occluded for 48 hours. The degree of erythema and oedema was evaluated at 1, 24 and 48 hours after dressing removal. The highest concentration that produced mild to moderate dermal irritation was selected for the topical induction stage of the main study.
Topical challenge: The undiluted test substance and 75, 50 and 25% v/v in arachis oil B.P. were applied under an occlusive dressing to two guinea pigs for 24 hours. Erythema was evaluated at 1, 24 and 48 hours after dressing removal. The highest non-irritant concentration and one lower concentration were selected for the topical challenge stage of the main study.
MAIN STUDY
A. INDUCTION EXPOSURE
Shortly before treatment on Day 0 the hair was removed from an area on the shoulder region of each animal. A row of three injections (0.1 ml) was made on each side of the mid-line. The injections were:
a) FCA plus distilled water in the ratio 1: 1
b) a 25% w/v solution of the test substance in arachis oil B.P.
c) a 25% w/v emulsion of the test substance in a 1:1 preparation of FCA plus distilled water.
Approximately 24 and 48 hours after the injection erythema at the test site was evaluated.
One week later (Day 7) the same area on the shoulder region used for the injections was clipped and treated with a topical application of the undiluted test substance. The patch was held in place with an occlusive dressing for 48 hours. The degree of erythema and oedema was scored 1 and 24 hours following removal of the patches.
Negative controls: Intradermal injections were:
a) FCA plus distilled water in the ratio 1: 1
b) arachis oil B.P.
c) a 50% w/v formulation of arachis oil B.P. in FCA/distilled water 1:1.
Topical applications followed the same procedure as for the test animals except that nothing was applied to the patch held under the occlusive dressing.
B. CHALLENGE EXPOSURE
Shortly before treatment on Day 21, an area on both flanks of each animal, was clipped. A patch of filter paper saturated with undiluted test substance was applied to the right flank and held in place with an occlusive dressing. A 75% v/v in arachis oil B.P. was similarly applied to the left flank (to ensure maximum non-irritant concentration used). After 24 hours the dressing was removed and the site swabed with cotton wool soaked in a suitable solvent. The degree of erythema and oedema was graded at 24 and 48 hours after patch removal. - Positive control substance(s):
- no
- Remarks:
- but historical positive controls for the laboratory reported.
- Positive control results:
- Historical positive controls gave appropriate results.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 100 %
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 75 %
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 100 %
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 75 %
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 100 %
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 75 %
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 100 %
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 75 %
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Reading:
- 1st reading
- Group:
- positive control
- Remarks on result:
- other: positive control was not included but historical controls were done periodically
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- In a guinea pig maximisation study conducted according to OECD Test Guideline 406 and in compliance with GLP, dicyclopentyl(dimethoxy)silane was not sensitising to the skin.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
Several guinea pig maximisation studies are available for this substance. These studies were all negative.
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
Justification for classification or non-classification
Based on the available data, dicyclopentyl(dimethoxy)silane does not meet the criteria for classification as a skin sensitiser according to Regulation (EC) No 1272/2008. There are no data to suggest that classification as a respiratory sensitiser is required.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.